Literature DB >> 1522216

Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.

A Krause1, G R Burmester, A Rensing, C Schoerner, U E Schaible, M M Simon, P Herzer, M D Kramer, R Wallich.   

Abstract

Patients with Lyme borreliosis (LB) usually develop a vigorous T cell response against the causative pathogen Borrelia burgdorferi, but little is known about the antigens recognized in the cellular response. Therefore, T cell reactivities against whole bacteria, recombinant 31-kD (outer surface protein A, [OspA]), and 41-kD proteins (flagellin) from B. burgdorferi were studied in patients with LB, non-LB patients, and healthy donors. In parallel, specific antibodies were determined by Western blot analysis. Virtually all patients with LB exhibited marked cellular responses to whole B. burgdorferi, which were significantly elevated compared with the control groups in both early and late disease stages. However, analyses using the purified antigens OspA and flagellin revealed considerable heterogeneity in the cellular reactivities among individuals as well as variations during the course of infection. T cell responses to OspA were significantly increased in patients with early LB compared with both control groups whereas in late-stage disease responses only exceeded those of non-LB patients and were not different from normal donors. Cellular immune reactivities to flagellin were significantly higher only in early LB compared with both control groups. Reciprocally, several control subjects demonstrated marked cellular responses to OspA and flagellin, suggesting that reactions to these proteins may not always be related to LB. T cell reactivity did not correlate well with the presence of specific antibodies. Almost all seropositive patients in both early and late stage LB had serum antibodies against flagellin, but antibodies to OspA were detectable only in a subset of late LB sera. These data demonstrate the complexity of the humoral and the cellular immune responses to components of B. burgdorferi.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1522216      PMCID: PMC329967          DOI: 10.1172/JCI115923

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates.

Authors:  A G Barbour; R A Heiland; T R Howe
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

2.  Cloning and sequencing of the gene encoding the outer surface protein A (OspA) of a European Borrelia burgdorferi isolate.

Authors:  R Wallich; U E Schaible; M M Simon; A Heiberger; M D Kramer
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

3.  Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease.

Authors:  K Hansen; P Hindersson; N S Pedersen
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

4.  Lyme disease-a tick-borne spirochetosis?

Authors:  W Burgdorfer; A G Barbour; S F Hayes; J L Benach; E Grunwaldt; J P Davis
Journal:  Science       Date:  1982-06-18       Impact factor: 47.728

5.  Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice.

Authors:  U E Schaible; M D Kramer; K Eichmann; M Modolell; C Museteanu; M M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease.

Authors:  R L Grodzicki; A C Steere
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

7.  [Serodiagnosis of Lyme borreliosis: antibody titer and specificity in the IFT and western blot].

Authors:  W Grellner; F Erbguth; V Brade
Journal:  Immun Infekt       Date:  1989-12

8.  Cellular immune response in Lyme disease: the response to mitogens, live Borrelia burgdorferi, NK cell function and lymphocyte subsets.

Authors:  R J Dattwyler; J A Thomas; J L Benach; M G Golightly
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-12

9.  Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice.

Authors:  M M Simon; U E Schaible; M D Kramer; C Eckerskorn; C Museteanu; H K Müller-Hermelink; R Wallich
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

10.  The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis.

Authors:  U E Schaible; M D Kramer; C Museteanu; G Zimmer; H Mossmann; M M Simon
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  24 in total

1.  Complement receptor 3 binds the Borrelia burgdorferi outer surface proteins OspA and OspB in an iC3b-independent manner.

Authors:  Rodolfo C Garcia; Rossella Murgia; Marina Cinco
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis.

Authors:  S Priem; M G Rittig; T Kamradt; G R Burmester; A Krause
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients.

Authors:  I Diterich; L Härter; D Hassler; A Wendel; T Hartung
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Detection of Borrelia burgdorferi DNA in urine of patients with ocular Lyme borreliosis.

Authors:  U Pleyer; S Priem; L Bergmann; G Burmester; C Hartmann; A Krause
Journal:  Br J Ophthalmol       Date:  2001-05       Impact factor: 4.638

5.  Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys.

Authors:  G H Giambartolomei; V A Dennis; M T Philipp
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis.

Authors:  B K DuChateau; J R Jensen; D M England; S M Callister; S D Lovrich; R F Schell
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease.

Authors:  R A Kalish; J M Leong; A C Steere
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

8.  The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor.

Authors:  H Fuchs; R Wallich; M M Simon; M D Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

9.  Variant responses of mice to Borrelia burgdorferi depending on the site of intradermal inoculation.

Authors:  M S de Souza; A L Smith; D S Beck; L J Kim; G M Hansen; S W Barthold
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis.

Authors:  L C Lim; D M England; B K DuChateau; N J Glowacki; R F Schell
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.